Nicole Walker joined Baird Capital's Venture Capital team in 2013 and focuses on healthcare investments. Nicole is a current member of the Board of Directors at Palyon Medical Corporation, NeuMoDx and Molecular Imaging.
Prior to joining Baird Capital, Nicole was with Abbott Ventures, where she managed the strategic planning, market development, and product portfolio initiatives for multiple brands in discrete and continuous blood glucose monitoring.
Before Abbott, she was with ONSET Ventures, where she specialized in seed and early-stage healthcare technology investments, and also worked for Guidant Corporation where she held a variety of roles within operations, product design & development, engineering management, and marketing.
Nicole received a BS in Mechanical Engineering from Stanford University, her MBA from the Kellogg School of Management and her MEM (Masters of Engineering Management) from the McCormick School of Engineering at Northwestern University.
Fund's investment verticals: technology-enabled services and healthcare.
MEDIA ABOUT NICOLE WALKER